<DOC>
	<DOCNO>NCT00711230</DOCNO>
	<brief_summary>DermaVir synthetic pathogen-like nanomedicine . The active pharmaceutical ingredient single plasmid DNA express fifteen HIV antigens assemble HIV-like particle . These particle safe ; replication , integration reverse transcription deficient . DermaVir target Langerhans cell topical administration DermaPrep . Langerhans cell DermaVir migrate lymph node induce HIV-specific T cell kill HIV-infected cell . GIEU006 Phase II randomize , placebo-controlled , dose-finding , double-blinded , multicenter study ass safety , tolerability , immunogenicity , preliminary antiretroviral activity DermaVir antiretroviral therapy naïve adult HIV-infection .</brief_summary>
	<brief_title>Repeated DermaVir Immunizations HIV-1 Infected Treatment-naïve Patients</brief_title>
	<detailed_description>Patients randomize one follow 6 arm : - Arm 1 : Low dose DermaVir ( 0.2 mg DNA 2 DermaPrep patch , n=9 ) - Arm 2 : Low dose Placebo ( 2 DermaPrep patch , n=3 ) - Arm 3 : Medium dose DermaVir ( 0.4 mg DNA 4 DermaPrep patch , n=9 ) - Arm 4 : Medium dose Placebo ( 4 DermaPrep patch , n=3 ) - Arm 5 : High dose DermaVir ( 0.8 mg DNA 8 DermaPrep patch , n=9 ) - Arm 6 : High dose Placebo ( 8 DermaPrep patch , n=3 ) DermaPrep Patch size : 80 cm2 . DermaVir Standard Unit per patch 0.1 mg DNA = 0.8 mL DermaVir nanomedicine . The patch sit immunization preferably leave right upper back leave right upper ventral thigh . The skin site use immunization . Immunization schedule ( Days ) : 0 , 42 , 84 , 126 . The total DermaVir dose : - Low dose : 0.8 mg DNA - Medium dose : 1.6 mg DNA - High Dose : 3.2 mg DNA DermaVir immunization administer 18-week period Primary endpoint : 24 week Safety follow : 234 week</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Main inclusion Criteria : HIV antibody positive Plasma HIV RNA value ≥5,000 copies/mL ≤ 150,000 c/mL Antiretroviral therapy naïve Documented CD4+ Tcell count screen ≥400 cells/mm3 Main exclusion Criteria : No skin disease No tattoo , change pigmentation select skin immunization sit No acute chronic illness ( e.g Hepatitis C ) No chronic autoimmune diseases No treatment immune modulate agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Immune Therapy</keyword>
	<keyword>DermaVir</keyword>
</DOC>